普卢利沙星置于三乙胺体系中,用 甲醇,二氯甲烷 用作溶剂,化学反应 1.5H,反应生成普卢利沙星 参考文献: Process For The Preparation Of Highly Pure Prulifloxacin[fr] Procédé D'élaboration De Prulifloxacine Hautement Pure 标题: Process For The Preparation Of Highly Pure Prulifloxacin[fr] Procédé D'élaboration De Prulifloxacine Hautement Pure 摘要:本发明提供了一种工业上有利的工艺,用于制备高纯度的化学式i的普鲁氟沙星及其药用可接受的盐.本发明还提供了一种用于纯化普鲁氟沙星酸盐的新工艺.
专利号:CN-101418005-B 优先权日:2008-12-22 标 题:A new method for the synthesis of prulifloxacin
专利号:CN-101418005-A 优先权日:2008-12-22 标题:A new method for the synthesis of prulifloxacin
专利号:CN-1704419-A 优先权日:2004-06-04 标 题:Process for synthesis of prulifloxacin and its pharmaceutical composition
专利号:US-2014315720-A1 优先权日:2012-10-24 标 题 :Polysaccharide ester microspheres and methods and articles relating thereto 发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY 权利人:CELANESE ACETATE LLC 摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.
专利号:CN-101711763-B 优先权日:2009-08-06 标题 :Prulifloxacin composition and preparation method thereof, and synthesis method of raw material drugs
专利号:CN-101711763-A 优先权日:2009-08-06 标题:Prulifloxacin composition and preparation method thereof, and synthesis method of raw material drugs
1: Chen J, Zhang L, Huang Y, Zhou Y, Yu Y, Li X. Quantitative study of ternary polycrystalline mixtures of prulifloxacin based on Raman spectra and Raman imaging maps. J Pharm Biomed Anal. 2024 Jan 20;238:115799. doi: 10.1016/j.jpba.2023.115799. Epub 2023 Oct 14. 16(12):2709-2718. doi: 10.1111/cts.13665. Epub 2023 Oct 28. 3: Cooper TE, Teng C, Howell M, Teixeira-Pinto A, Jaure A, Wong G. D-mannose for preventing and treating urinary tract infections. Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD013608. doi: 10.1002/14651858.CD013608.pub2. 4: Tulone G, Giannone S, Mannone P, Tognarelli A, Di Vico T, Giaimo R, Zucchi A, Rossanese M, Abrate A, Pavan N, Claps F, Ficarra V, Bartoletti R, Simonato A. Comparison of Fluoroquinolones and Other Antibiotic Prophylaxis Regimens for Preventing Complications in Patients Undergoing Transrectal Prostate Biopsy. Antibiotics (Basel). 2022 Mar 20;11(3):415. doi: 10.3390/antibiotics11030415.
合成参考文献
参考文献:10.1007/s11894-011-0208-6 摘要:Paredes-Paredes M, Flores-Figueroa J, Dupont HL. Advances in the treatment of travelers' diarrhea. Curr Gastroenterol Rep. 2011 Oct;13(5):402–7. doi: 10.1007/s11894-011-0208-6.